![](/img/cover-not-exists.png)
A Phase 4 Study of Everolimus to Evaluate Efficacy and Safety in Patients with Metastatic Renal-Cell Carcinoma after Failure of First-Line Sunitinib or Pazopanib (SUNPAZ)
Schostak, Martin, de Geeter, Patrick, Decker, Thomas, Resch, Anna, Quiering, Claudia, Schmitz, StephanLanguage:
english
Journal:
Urologia Internationalis
DOI:
10.1159/000503870
Date:
November, 2019
File:
PDF, 262 KB
english, 2019